Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barbara Lopez Kunz Insider Profile
4 Followers
Barbara Lopez Kunz, Director at Aptevo Therapeutics, holds 198.00 shares in Aptevo Therapeutics (Ticker: APVO).
Barbara Lopez Kunz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Barbara Lopez Kunz's holdings
Insider Roles
Director
Roles that Barbara Lopez Kunz holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 11, 2019 - Jun 11, 2020
Return:-56.50%
The most profitable trade made by Barbara Lopez Kunz
Barbara Lopez Kunz's Trading History
List of latest transactions for each holding click on a transaction to see Barbara Lopez Kunz's performance on stock
You May Also Like
Barbara Lopez Kunz insider profile FAQ
What is the percentage of profitable transactions made by Barbara Lopez Kunz?
The percentage of profitable transactions made by Barbara Lopez Kunz is ―.
What is the average return per transaction made by Barbara Lopez Kunz?
The average return per transaction made by Barbara Lopez Kunz is ―.
What stocks does Barbara Lopez Kunz hold?
Barbara Lopez Kunz holds: APVO stocks.
What was Barbara Lopez Kunz’s latest transaction?
Barbara Lopez Kunz latest transaction was an Uninformative Buy of $62.65.
What was Barbara Lopez Kunz's most profitable transaction?
Barbara Lopez Kunz’s most profitable transaction was an Informative Buy of APVO stock on June 11, 2019. The return on the trade was -56.50%.
What is Barbara Lopez Kunz's role in Aptevo Therapeutics?
Barbara Lopez Kunz's role in Aptevo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.